Bronson Crouch
Chief Executive Officer at INSTIL BIO, INC.
Net worth: 22 M $ as of 2024-04-29
Network origin in Bronson Crouch first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 15 | |
| Subsidiary | Pharmaceuticals: Major | 14 | |
| Subsidiary | Pharmaceuticals: Major | 6 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Bronson Crouch via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| KITE PHARMA INC | Biotechnology | Private Equity Investor Chief Tech/Sci/R&D Officer Private Equity Investor Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Stanford University | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree | |
| ALLOGENE THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Founder Chief Tech/Sci/R&D Officer | |
| The University of Chicago | College/University | Masters Business Admin Doctorate Degree | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree | |
| REATA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| The Pennsylvania State University | College/University | Masters Business Admin Undergraduate Degree | |
| University of Cambridge | College/University | Graduate Degree Doctorate Degree | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | General Counsel Corporate Officer/Principal | |
| BIVICTRIX THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| University of Illinois At Urbana–Champaign | College/University | Graduate Degree Undergraduate Degree | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Public Communications Contact | |
Vida Ventures LLC
 Vida Ventures LLC Investment ManagersFinance Vida Ventures LLC invests in companies located in the United States. The fund targets companies operating in the fields of life science innovation. It provides financing for seed, early and later stage capital requirements. | Investment Managers | Corporate Officer/Principal Director/Board Member | |
VV Manager LLC
 VV Manager LLC Investment ManagersFinance VV Manager LLC (Vida Ventures) is a venture capital firm founded in 2017 by Arie Belldegrun, Arjun Goyal and Stefan Vitorovic. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Consultant / Advisor | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Undergraduate Degree Graduate Degree | |
| The University of Texas at Austin | College/University | Undergraduate Degree Undergraduate Degree | |
| APOLLO ENDOSURGERY, INC. | Medical Specialties | Director/Board Member Director/Board Member | |
| AMGEN INC. | Pharmaceuticals: Major | Private Equity Investor Chief Tech/Sci/R&D Officer | |
A2 Biotherapeutics, Inc.
 A2 Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services A2 Biotherapeutics, Inc. operates as a biotechnology company. It develops medicines. The company was founded by Alexander Kamb, Michael Gallo and Paul Kang in 2018 and is headquartered in Westlake Village, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
PACT Pharma, Inc.
 PACT Pharma, Inc. Pharmaceuticals: MajorHealth Technology PACT Pharma, Inc. develops pharmaceutical products. It offers personalizes adoptive cell therapies with neoantigen-targeted T cells against cancer. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member President | |
IconOVir Bio, Inc.
 IconOVir Bio, Inc. BiotechnologyHealth Technology IconOVir Bio, Inc. is an American biotechnology company that operates in the field of life sciences. The company was founded in 2018 by Arie S. Belldegrun, Ben Stone. The CEO is Mark A. McCamish. | Biotechnology | Director/Board Member Chairman | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| ADAPTIMMUNE THERAPEUTICS PLC | Biotechnology | Chief Operating Officer Chief Tech/Sci/R&D Officer | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree Undergraduate Degree | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree | |
Syneos Health Consulting, Inc.
 Syneos Health Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services Syneos Health Consulting, Inc. provides consulting services to pharmaceutical and biotech industries. It is organized into practice areas, each specializing in a critical industry function: brand management, business development, clinical development, managed markets, medical affairs, sales, and trade and distribution. The company was founded by John J. Campbell in 1997 and is headquartered in Morrisville, NC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Surveyor Capital Ltd.
 Surveyor Capital Ltd. Investment ManagersFinance Surveyor Capital Ltd. is a hedge fund seeding platform headquartered in New York City. The firm was founded in 2008 and is a subsidiary of Citadel LP, which is owned by GFH HFEVA LLC. Surveyor Capital manages capital exclusively for Citadel’s multi-strategy funds and its positions are consolidated in Form 13F filed by Citadel Advisors LLC. | Investment Managers | Analyst-Equity | |
Venrock Associates
 Venrock Associates Investment ManagersFinance Venrock Associates is an Independent Venture Capital firm founded in 1969. The firm is headquartered in Palo Alto. | Investment Managers | Private Equity Investor | |
| Mailman School of Public Health | College/University | Graduate Degree | |
Jones Day LP
 Jones Day LP Miscellaneous Commercial ServicesCommercial Services Jones Day LP provides legal services. It offers services to the airlines, aviation, automotive, construction, energy, healthcare, insurance, media, pharmaceuticals, and telecommunication industries. The company was founded by Edwin J. Blandin and William Lowe Rice on March 1, 1893 and is headquartered in Cleveland, OH. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Columbia Business School | College/University | Masters Business Admin | |
| APOGEE THERAPEUTICS, INC. | Biotechnology | Founder | |
| SOLITON, INC. | Medical Specialties | Director/Board Member | |
Remeditex Ventures LLC
 Remeditex Ventures LLC Investment ManagersFinance Remeditex Ventures LLC (Remeditex Ventures) is a venture capital firm founded in 2011. The firm is headquartered in Dallas, Texas. | Investment Managers | President | |
| The University of Texas School of Law | College/University | Graduate Degree | |
| David Geffen School of Medicine | College/University | Corporate Officer/Principal | |
Credit Suisse Securities (USA) LLC (Broker)
 Credit Suisse Securities (USA) LLC (Broker) Investment Banks/BrokersFinance Credit Suisse Securities (USA) LLC (Credit Suisse Securities USA) is the broker/dealer division of Credit Suisse Securities (USA) LLC, an investment banking company headquartered in New York City. The firm was founded in 1998 and is a wholly owned subsidiary of Credit Suisse (USA), Inc., ultimately owned by Credit Suisse Group AG (SWX: CSGN) in Switzerland. Credit Suisse Securities USA offers a suite of equities, solutions and credit products and services which includes global securities sales, trading and execution, prime brokerage and comprehensive investment research. Their clients include financial institutions, corporations, governments, institutional investors, such as pension funds and hedge funds, and private individuals around the world. | Investment Banks/Brokers | Analyst-Equity | |
VuCOMP, Inc.
 VuCOMP, Inc. Information Technology ServicesTechnology Services VuCOMP, Inc. designs and develops computer aided detection systems for mammography. It offers M-Vu system, a medical device that screens mammogram images for abnormalities such as masses, architectural distortions, and calcifications. The company was founded by James Pike in 2001 and is headquartered in Plano, TX. | Information Technology Services | Director/Board Member | |
| Vivo Co-Invest (S) LP | Director/Board Member | ||
Ocelot Bio, Inc.
 Ocelot Bio, Inc. Pharmaceuticals: MajorHealth Technology Ocelot Bio, Inc. is a clinical-stage biopharmaceutical company that focuses on improving outcomes for patients with end-stage liver disease (ESLD), particularly those suffering from hepatorenal syndrome with acute kidney injury (HRS-AKI) and refractory ascites. The company is based in San Diego, CA. The company is developing therapeutic peptides to treat complications of decompensated cirrhosis, a condition in which the liver is scarred and permanently damaged, leading to liver failure. HRS-AKI is a life-threatening consequence of portal hypertension, which causes a significant drop in arterial pressure and renal perfusion. Ocelot Bio is in early-stage development of OCE-205 for the treatment of ascites, a complication of ESLD-induced portal hypertension that leads to the accumulation of fluid in the peritoneal cavity. The company was founded by Geoffrey Harris, and Katherine Vega Stultz has been the CEO of the company since 2022. | Pharmaceuticals: Major | Director/Board Member | |
| The University of Tulsa | College/University | Undergraduate Degree | |
CSL Behring LLC
 CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Biotechnology | Chief Operating Officer | |
International Society for Pharmaceutical Engineering
 International Society for Pharmaceutical Engineering Miscellaneous Commercial ServicesCommercial Services The International Society for Pharmaceutical Engineering is a nonprofit association that focuses on scientific, technical, and regulatory advancement throughout the entire pharmaceutical lifecycle. The non-profit company is based in Tampa, FL. The company engages with all levels of regulators to ensure that their education, training, document development, and interpretation are cutting-edge and focused on enabling the production and supply of therapies and devices with unmatched levels of flow, efficiency, and quality sustainably and at scale. John Bournas has been the CEO of the company since 2015. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Parenteral Drug Association | Corporate Officer/Principal | ||
| CERUS CORPORATION | Medical Specialties | Director/Board Member |
Statistics
International
| United States | 48 |
| United Kingdom | 4 |
Sectoral
| Health Technology | 23 |
| Consumer Services | 15 |
| Finance | 8 |
| Commercial Services | 5 |
| Technology Services | 2 |
Operational
| Director/Board Member | 115 |
| Corporate Officer/Principal | 73 |
| Independent Dir/Board Member | 29 |
| Undergraduate Degree | 25 |
| Chief Tech/Sci/R&D Officer | 23 |
Most connected contacts
| Insiders | |
|---|---|
| Jack Nielsen | 38 |
| Helen Kim | 34 |
| Richard McGaughy | 21 |
| Neil Gibson | 20 |
| William Bertrand | 16 |
| David Chang | 16 |
| Timothy Moore | 15 |
| Sandeep Laumas | 14 |
| John Moore | 12 |
| Sumita Ray | 12 |
| Nimish Shah | 10 |
| Gwendolyn Binder-Scholl | 8 |
| Brett A. Ringle | 8 |
| Kevin Zikaras | 7 |
| Peter Olagunju | 7 |
- Stock Market
- Insiders
- Bronson Crouch
- Company connections
